基于CRISPR/Cas9系统高通量筛选研究功能基因

doi:10.16288/j.yczz.15-329

遗传 ›› 2016, Vol. 38 ›› Issue (5): 391-401.doi: 10.16288/j.yczz.15-329

基于CRISPR/Cas9系统高通量筛选研究功能基因

王干诚¹, 马明¹, 叶延帧¹, 席建忠^{1, 2, 3}

1. 北京大学工学院生物医学工程系,北京 100871;
2. 北京大学生物膜和膜技术国家重点实验室,分子医学研究所,北京 100871;
3. 北京大学天然药物及仿生药物国家重点实验室,北京 100871

收稿日期:2015-10-25 修回日期:2016-01-21 出版日期:2016-05-20 发布日期:2016-02-24
通讯作者: 席建忠,博士,教授,研究方向：生物医学工程。Tel: 010-62760698; E-mail: jzxi@pku.edu.cn E-mail:wgcd@pku.edu.cn
作者简介:王干诚,硕士研究生,专业方向：生物医学工程。E-mail: wgcd@pku.edu.cn

High-throughput functional screening using CRISPR/Cas9 system

Gancheng Wang¹, MingMa¹, Yanzhen Ye¹, Jianzhong Xi^{1, 2, 3}

1. Department of Biomedicine, College of Engineering, Peking University, Beijing 100871, China;
2. State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Molecular Medicine, Peking University, Beijing 100871, China;
3. State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100871, China

Received:2015-10-25 Revised:2016-01-21 Online:2016-05-20 Published:2016-02-24

摘要/Abstract

摘要： 利用功能缺失型(Loss-of-function)或者功能获得型(Gain-of-function) 策略高通量筛选功能基因,是研究人员快速寻找调控特定表型的重要或关键基因的主要方法。RNA干扰(RNA interference,RNAi)的遗传筛选方法因操作简单、成本相对较低等优势,尽管已经得到了广泛的应用,然而其抑制效果不完全、脱靶效应明显等劣势依然存在。近年来兴起的CRISPR/Cas9 (Clustered regularly interspaced short palindromic repeat sequences/ CRISPR-associated protein 9)技术能快速、简便、准确地实现基因组敲除等编辑功能,因而成为一种强大的遗传筛选工具;在各种细胞系、人和小鼠及斑马鱼等多种模式动物中,大规模运用该方法筛选功能基因已经取得了巨大成功。本文总结了CRISPR/Cas9技术的特点,将其与传统基因工程方法进行了分析比较,回顾了近期相关的高通量功能基因筛选工作,最后探讨了该技术未来的发展趋势。

关键词: CRISPR/Cas9, 基因组编辑技术, 高通量, 遗传筛选

Abstract: High-throughput screening, a powerful tool for the discovery of functionally important genes responsible for certain phenotypes, is performed according to loss-of-function or gain-of-function strategies. RNAi technology or knockout approaches have been widely used in high throughput screening due to their advantages of ease use, low cost and so on. However, imcomplete knockdown activity and off-target effect hindered their utility. More recently, CRISPR/Cas9 technology is becoming a robust tool for genome editing in diverse cells or animals, since it could generate a gene mutation in a target-specific manner. In this review, we first summarize the characterization of CRISPR/Cas9 and make comparison with traditional genetic tools, then describe recent achievements of genetic screen in several model organisms using CRISPR/Cas9, finally discuss on its future challenges and opportunities.

Key words: CRISPR/Cas9, genome editing technology, high-throughput, genetic screening

王干诚, 马明, 叶延帧, 席建忠. 基于CRISPR/Cas9系统高通量筛选研究功能基因[J]. 遗传, 2016, 38(5): 391-401.

Gancheng Wang, MingMa, Yanzhen Ye, Jianzhong Xi. High-throughput functional screening using CRISPR/Cas9 system[J]. HEREDITAS(Beijing), 2016, 38(5): 391-401.

参考文献

[1] Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli , and identification of the gene product. J Bacteriol , 1987, 169(12): 5429-5433.
[2] Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. CRISPR provides acquired resistance against viruses in prokaryotes. Science , 2007, 315(5819): 1709-1712.
[3] Cong L, Ran FA, Cox D, Lin SL, Barretto R, Habib N, Hsu PD, Wu XB, Jiang WY, Marraffini LA, Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science , 2013, 339(6121): 819-823.
[4] Mali P, Yang LH, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. RNA-guided human genome engineering via Cas9. Science , 2013, 339(6121): 823-826.
[5] Li J, Zhang Y, Chen KL, Shan QW, Wang YP, Liang Z, Gao CX. CRISPR/Cas: a novel way of RNA-guided genome editing. Hereditas (Beijing) , 2013, 35(11): 1265-1273. 李君, 张毅, 陈坤玲, 单奇伟, 王延鹏, 梁振, 高彩霞. CRISPR/Cas系统: RNA靶向的基因组定向编辑新技术. 遗传, 2013, 35(11): 1265-1273.
[6] Ohrt T, Merkle D, Birkenfeld K, Echeverri CJ, Schwille P. In situ fluorescence analysis demonstrates active siRNA exclusion from the nucleus by Exportin 5. Nucleic Acids Res , 2006, 34(5): 1369-1380.
[7] Hartenian E, Doench JG. Genetic screens and functional genomics using CRISPR/Cas9 technology. FEBS J , 2015, 282(8): 1383-1393.
[8] Shalem O, Sanjana NE, Zhang F. High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet , 2015, 16(5): 299-311.
[9] Xi JZ, Ma M, Wang GC, Luo YF. Development and perspective of high-throughput siRNA screening technology. Chin Bull Life Sci , 2014, 26(3): 276-286. 席建忠, 马明, 王干诚, 骆宇峰. 高通量siRNA筛选技术发展与展望. 生命科学, 2014, 26(3): 276-286.
[10] Echeverri CJ, Beachy PA, Baum B, Boutros M, Buchholz F, Chanda SK, Downward J, Ellenberg J, Fraser AG, Hacohen N, Hahn WC, Jackson AL, Kiger A, Linsley PS, Lum L, Ma Y, Mathey-Prévôt B, Root DE, Sabatini DM, Taipale J, Perrimon N, Bernards R. Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods , 2006, 3(10): 777-779.
[11] Westbrook TF, Martin ES, Schlabach MR, Leng YM, Liang AC, Feng B, Zhao JJ, Roberts TM, Mandel G, Hannon GJ, DePinho RA, Chin L, Elledge SJ. A genetic screen for candidate tumor suppressors identifies REST. Cell , 2005, 121(6): 837-848.
[12] Luo B, Cheung HW, Subramanian A, Sharifnia T, Okamoto M, Yang XP, Hinkle G, Boehm JS, Beroukhim R, Weir BA, Mermel C, Barbie DA, Awad T, Zhou X, Nguyen T, Piqani B, Li C, Golub TR, Meyerson M, Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE. Highly parallel identification of essential genes in cancer cells. Proc Natl Acad Sci USA , 2008, 105(51): 20380-20385.
[13] Zhou YX, Zhu SY, Cai CZ, Yuan PF, Li CM, Huang YY, Wei WS. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature , 2014, 509(7501): 487-491.
[14] Wang T, Wei JJ, Sabatini DM, Lander ES. Genetic screens in human cells using the CRISPR-Cas9 system. Science , 2014, 343(6166): 80-84.
[15] Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG, Zhang F. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science , 2014, 343(6166): 84-87.
[16] Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. Mutations of the BRAF gene in human cancer. Nature , 2002, 417(6892): 949-954.
[17] Wang T, Birsoy K, Hughes NW, Krupczak KM, Post Y, Wei JJ, Lander ES, Sabatini DM. Identification and characterization of essential genes in the human genome. Science , 2015, 350(6264): 1096-1101.
[18] Koike-Yusa H, Li YL, Tan EP, Velasco-Herrera Mdel C, Yusa K. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol , 2014, 32(3): 267-273.
[19] Chen SD, Sanjana NE, Zheng KJ, Shalem O, Lee K, Shi X, Scott DA, Song J, Pan JQ, Weissleder R, Lee H, Zhang F, Sharp PA. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell , 2015, 160(6): 1246-1260.
[20] Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen YW, Whitehead EH, Guimaraes C, Panning B, Ploegh HL, Bassik MC, Qi LS, Kampmann M, Weissman JS. Genome-scale CRISPR-mediated control of gene repression and activation. Cell , 2014, 159(3): 647-661.
[21] Tanenbaum ME, Gilbert LA, Qi LS, Weissman JS, Vale RD. A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell , 2014, 159(3): 635-646.
[22] Bikard D, Jiang WY, Samai P, Hochschild A, Zhang F, Marraffini LA. Programmable repression and activation of bacterial gene expression using an engineered CRISPR- Cas system. Nucleic Acids Res , 2013, 41(15): 7429-7437.
[23] Konermann S, Brigham MD, Trevino AE, Joung J, Abudayyeh OO, Barcena C, Hsu PD, Habib N, Gootenberg JS, Nishimasu H, Nureki O, Zhang F. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature , 2015, 517(7536): 583-588.
[24] Zalatan JG, Lee ME, Almeida R, Gilbert LA, Whitehead EH, La Russa M, Tsai JC, Weissman JS, Dueber JE, Qi LS, Lim WA. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell , 2015, 160(1-2): 339-350.
[25] Doench JG, Hartenian E, Graham DB, Tothova Z, Hegde M, Smith I, Sullender M, Ebert BL, Xavier RJ, Root DE. Rational design of highly active sgRNAs for CRISPR- Cas9-mediated gene inactivation. Nat Biotechnol , 2014, 32(12): 1262-1267.
[26] Fu YF, Sander JD, Reyon D, Cascio VM, Joung JK. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol , 2014, 32(3): 279-284.
[27] Zheng W, Gu F. Progress of application and off-target effects of CRISPR/Cas9. Hereditas ( Beijing ), 2015, 37(10): 1003-1010. 郑武, 谷峰. CRISPR/Cas9的应用及脱靶效应研究进展. 遗传, 2015, 37(10): 1003-1010.
[28] Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, Zhang F. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell , 2013, 154(6): 1380-1389.
[29] Ran FA, Cong L, Yan WX, Scott DA, Gootenberg JS, Kriz AJ, Zetsche B, Shalem O, Wu XB, Makarova KS, Koonin EV, Sharp PA, Zhang F. In vivo genome editing using Staphylococcus aureus Cas9. Nature , 2015, 520(7546): 186-191.
[30] Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, van der Oost J, Regev A, Koonin EV, Zhang F. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell , 2015, 163(3): 759-771.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

基于CRISPR/Cas9系统高通量筛选研究功能基因

High-throughput functional screening using CRISPR/Cas9 system

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	郑晓飞,黄海燕,吴强. 染色质架构蛋白CTCF调控UGT1基因簇的表达[J]. 遗传, 2019, 41(6): 509-523.
[2]	王珏, 黄娟, 许蕊. 利用CRISPR/Cas9和piggyBac实现果蝇基因组无缝编辑[J]. 遗传, 2019, 41(5): 422-429.
[3]	刘刚,孙飞舟,朱芳贤,冯海永,韩旭. 连续性纯合片段在畜禽基因组研究中的应用[J]. 遗传, 2019, 41(4): 304-317.
[4]	石田培,张莉. 全转录组学在畜牧业中的应用[J]. 遗传, 2019, 41(3): 193-205.
[5]	张楷, 刘蔚, 刘小凤, 陈瑶生, 刘小红, 何祖勇. 利用CRISPR/Cas9系统构建人HPRT1基因定点突变细胞株[J]. 遗传, 2019, 41(10): 939-949.
[6]	刘恒, 李东明, 朱兰玉, 赖乐锦, 闫婉云, 陆玉双, 韦伊, 黄月琪, 方媚, 苏元港, 杨芳, 舒伟. 利用CRISPR/Cas9敲除人源细胞系中LMNA基因的研究[J]. 遗传, 2019, 41(1): 66-75.
[7]	任云晓, 肖茹丹, 娄晓敏, 方向东. 基因编辑技术及其在基因治疗中的应用[J]. 遗传, 2019, 41(1): 18-27.
[8]	张桂珊, 杨勇, 张灵敏, 戴宪华. 机器学习方法在CRISPR/Cas9系统中的应用[J]. 遗传, 2018, 40(9): 704-723.
[9]	刘海龙, 谌阳, 高杨, 周玲, 韩晓松, 赵长志, 杨高娟, 陈毅龙, 杨慧, 谢胜松. 靶向miRNA前体不同类型sgRNA的丰度及特异性评估[J]. 遗传, 2018, 40(7): 561-571.
[10]	唐浚博, 曹浩伟, 许蕊, 张丹丹, 黄娟. 果蝇睾丸基因敲除突变体的构建及表型分析[J]. 遗传, 2018, 40(6): 478-487.
[11]	李慧卿, 陈超, 陈冉冉, 宋雪薇, 李佶娜, 朱延明, 丁晓东. 利用CRISPR/Cas9双基因敲除系统初步解析大豆GmSnRK1.1和GmSnRK1.2对ABA及碱胁迫的响应[J]. 遗传, 2018, 40(6): 496-507.
[12]	童晓玲,方春燕,盖停停,石津,鲁成,代方银. CRISPR/Cas9系统在昆虫中的应用[J]. 遗传, 2018, 40(4): 266-278.
[13]	谢晶, 范辰, 张景龙, 张仕强. Ash2l-1/Ash2l-2在小鼠胚胎干细胞中的表达特异性及互补效应[J]. 遗传, 2018, 40(3): 237-249.
[14]	辛高伟, 胡熙璕, 王克剑, 王兴春. Cas9蛋白变体VQR高效识别水稻NGAC前间区序列邻近基序[J]. 遗传, 2018, 40(12): 1112-1119.
[15]	刘旭, 张平, 张晓枫, 李兴, 白宇, 贾克荣, 郭晓东, 张豪, 马晓燕, 仓明, 刘东军, 郭旭东. 利用CRISPR/Cas9系统构建FGF21基因敲除小鼠模型[J]. 遗传, 2018, 40(1): 66-74.